- Abstract:
-
The effect of alteplase on patient survival after ischaemic stroke is the subject of debate. We report the effect of intravenous alteplase on long-term survival after ischaemic stroke of participants in the Third International Stroke Trial (IST-3).In IST-3, done at 156 hospitals in 12 countries (Australia, Europe, and the UK), participants (aged >18 years) were randomly assigned with a telephone voice-activated or web-based system in a 1:1 ratio to treatment with intravenous 0·9 mg/kg alte...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Version:
- Accepted Manuscript
- Publisher:
- Elsevier Publisher's website
- Journal:
- Lancet Neurology Journal website
- Volume:
- 15
- Issue:
- 10
- Pages:
- 1028-1034
- Publication date:
- 2016-07-20
- Acceptance date:
- 2016-06-13
- DOI:
- EISSN:
-
1474-4465
- ISSN:
-
1474-4422
- Pubs id:
-
pubs:636470
- URN:
-
uri:036da67b-cad2-4802-95f6-66d8c476a37a
- UUID:
-
uuid:036da67b-cad2-4802-95f6-66d8c476a37a
- Local pid:
- pubs:636470
- Language:
- English
- Keywords:
- Copyright holder:
- Elsevier Ltd
- Copyright date:
- 2016
- Notes:
- © 2016 Elsevier Ltd. All rights reserved. This is the accepted manuscript version of the article. The final version is available online from Elsevier at: https://doi.org/10.1016/S1474-4422(16)30139-9
Journal article
Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial
Actions
Authors
Funding
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record